Haemonetics stock kpis
Want to see HAE full AI Analyst Report?
Net Revenue by Segment
Tracks sales across product and service lines, showing which offerings—such as devices, consumables, and service contracts—are driving growth. For Haemonetics, a rising share of consumables or recurring service revenue points to steadier, more predictable cash flow tied to an installed base, while reliance on one-time equipment sales can make top-line performance more cyclical.
Recent quarter shows a dramatic Apheresis jump that aligns with management’s Apheresis disclosure—part real growth from Persona PLUS rollout and part reporting/reclassification, so treat it as both product momentum and a structural change. MedSurg exhibits sustained, multi‑quarter strength and supports upgraded guidance, while Plasma is steady but management remains cautious on volumes. Blood Center and Other have slumped—timing and working‑capital boosts inflated cash; watch margin pressure and OEM/IVT softness for downside risk.
HAE Net Revenue by Segment
| Date | Other | Plasma | Blood Center | Apheresis | Medsurg |
|---|---|---|---|---|---|
| Sep 30, 2026 | $0.00 | $0.00 | $0.00 | $204.81M | $152.95M |
| Jun 30, 2026 | $0.00 | $0.00 | $0.00 | $191.32M | $148.06M |
| Mar 31, 2026 | $0.00 | $130.30M | $56.40M | $0.00 | $159.60M |
| Dec 31, 2025 | $0.00 | $138.91M | $56.56M | $0.00 | $143.50M |
| Sep 30, 2025 | $0.00 | $125.36M | $56.45M | $0.00 | $145.50M |
| Jun 30, 2025 | $0.00 | $129.90M | $51.84M | $0.00 | $139.66M |
| Mar 31, 2025 | $0.00 | $126.74M | $56.01M | $0.00 | $147.86M |
| Dec 31, 2024 | $0.00 | $134.22M | $70.34M | $0.00 | $143.97M |
| Sep 30, 2024 | $0.00 | $138.56M | $68.53M | $0.00 | $138.42M |
| Jun 30, 2024 | $0.00 | $135.91M | $66.25M | $0.00 | $134.02M |
| Mar 31, 2024 | $4.42M | $138.45M | $71.13M | $0.00 | $129.29M |
| Dec 31, 2023 | $4.12M | $146.72M | $71.61M | $0.00 | $113.79M |
| Sep 30, 2023 | $4.17M | $141.75M | $68.91M | $0.00 | $103.36M |
| Jun 30, 2023 | $6.01M | $138.48M | $67.31M | $0.00 | $99.54M |
| Mar 31, 2023 | -$453.00K | $131.99M | $70.31M | $0.00 | $102.57M |
| Dec 31, 2022 | -$1.99M | $136.57M | $76.83M | $0.00 | $93.89M |
| Sep 30, 2022 | $383.00K | $128.89M | $75.65M | $0.00 | $92.56M |
| Jun 30, 2022 | $2.66M | $103.04M | $66.57M | $0.00 | $89.18M |
| Mar 31, 2022 | $4.57M | $101.45M | $73.02M | $0.00 | $85.97M |
| Dec 31, 2021 | $6.45M | $96.69M | $74.53M | $0.00 | $82.10M |
| Sep 30, 2021 | $6.73M | $82.00M | $75.26M | $0.00 | $75.90M |
| Jun 30, 2021 | $7.38M | $71.80M | $71.74M | $0.00 | $77.61M |

